New-born screening refers to preventive screening tests conducted with the aim of earliest possible recognition of disorders for the prevention of severe disorders among new-borns. As per the analysis of Market Research Future (MRFR), the global new-born screening market is likely to capture a significant growth of 10.5% CAGR over the forecast period of 2018-2023.
Expanding neonatal population base is one of the preliminary factors fostering the growth of the global new-born screening market. Growing number of new-born babies induce high demand for screening since it can help in early identification and prevention of various heritable disorders.
Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/6561
Rising occurrence of various congenital disorders among new-borns significantly adds to the growth of the market. Congenital diseases among infants have been on the rise, early screening of which can help in the adoption of interventional step and prevent fatal disorder.
Technological advancements achieved in the field of screening methods such as tandem mass spectrometry, pulse oximetry have facilitated identification of a host of medical conditions in a single test.
Towering efforts undertaken by several welfare organizations such as the World Health Organization (WHO) to raise awareness regarding neonatal screening to assist the growth of the market. The governments in multiple countries have endeavored towards reducing infant mortality rates and have advanced support for the same. Various countries have mandated new-born screening which spurs the growth of the market.
On the contrary, the growth of the market might be constrained by the lack of knowledge and awareness regarding new-born screening. Other restraints include unreliability of new-born screening methods and lack of uniformity in policies and procedures.
Meanwhile, investment by private sector in new-born screening programs in developing countries is likely to present growth opportunities to the global new-born screening market.
Competitive Players:
The prominent players operating in the global new-born screening market include AB Sciex LLC (A Subsidiary of Danaher Corporation), GE Healthcare (A Subsidiary of General Electric Company), Trivitron Healthcare, Agilent Technologies Inc., ZenTech S.A, Natus Medical Incorporated, Perkinelmer, Inc., Covidien PLC, Bio-Rad Laboratories, Inc., Waters Corporation, and Masimo Corporation.
Segmentation
The global new-born screening market has been segmented based on technology, test type, product and end users. By technology, the market has been segmented into tandem mass spectrometry (TMS), electrophoresis, immunoassays, and enzymatic assays, DNA-based assays, hearing screening technology, pulse oximetry screening technology.
By test type, the market has been segmented into dry blood spot test, hearing screening test, critical congenital heart diseases (CCHD) test, urine test, and others.
By products, the market has been segmented into instruments and reagents and assay kits. The instruments segment has been further segmented into mass spectrometer, laparoscope, retinoscope, ultrasound machine, new-born hearing screening instruments, and pulse oximeters. The new-born hearing screening sub-segment has been further segmented into hearing screening devices and hearing screening accessories.
By end-users, the market has been segmented into hospitals, maternity & specialty clinics, diagnostic centers, and others.
Regional Analysis:
The Americas, Europe, Asia-Pacific, and the Middle East and Africa are the key markets for new-born screening. The Americas market has been further segmented into North America and South America. The North America market has been further segmented into the US and Canada. High healthcare awareness, government support, and advancement in technologies favor the growth of the Americas market. The Americas is the largest market for new-born screening.
Europe is the second largest market driven by increasing government funding and measures undertaken to prevent deaths of infants.
Asia Pacific is projected to be the fastest growing market for new-born screening. Rise in neonatal population, raising awareness, and implementation of favorable healthcare schemes by government agencies assist the growth of the Asia Pacific market. Quality assurance of newborn screening procedures in the economies of Sri Lanka, Taiwan, India, and China over the last few years have further aided the growth of the global new-born screening market in Asia Pacific.
The Middle East & Africa market accounts for the least share of the global market due to low awareness, low disposable income, the absence of technologically advanced instruments, and delay in hospitalization. Lack of proper healthcare infrastructure and socio-economic barriers are likely to restrain the growth of the market over the forecast period.
Browse Complete 85 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/new-born-screening-market-6561
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/new-born-screening-market-6561